Dyslipidaemia: Niacin-laropiprant fails to reduce the risk of vascular events
- PMID: 25093436
- DOI: 10.1038/nrcardio.2014.116
Dyslipidaemia: Niacin-laropiprant fails to reduce the risk of vascular events
Comment on
-
Effects of extended-release niacin with laropiprant in high-risk patients.N Engl J Med. 2014 Jul 17;371(3):203-12. doi: 10.1056/NEJMoa1300955. N Engl J Med. 2014. PMID: 25014686 Clinical Trial.
References
-
- N Engl J Med. 2014 Jul 17;371(3):203-12 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical